Browsing "Comunicações em Eventos - FM/MNE" by Title

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 115 to 134 of 316 < previous   next >
Issue DateTitleAuthor(s)
2020FDG-PET degeneration patterns predict amyloid deposition in Corticobasal SyndromePARMERA, J.; COUTINHO, A.; NETO, A.; ONO, C.; ARANHA, M.; BUCHPIGUEL, C.; NITRINI, R.; BARBOSA, E.; BRUCKI, S.
2021FIREFISH Part 2: 24-month Efficacy and Safety of Risdiplam in Infants with Type 1 Spinal Muscular Atrophy (SMA)DARRAS, Basil T.; MASSON, Ricardo z; MAZURKIEWICZ-BELDZINSKA, Maria; ROSE, Kristy; XIONG, Hui; ZANOTELI, Edmar; BARANELLO, Giovanni; VLODAVETS, Dmitry; DODMAN, Angela; EL-KHAIRI, Muna, et al
2020FIREFISH Part 2: Efficacy and safety of risdiplam (RG7916) in infants with Type 1 spinal muscular atrophy (SMA)BARANELLO, Giovanni; SERVAIS, Laurent; MASSON, Riccardo; MAZURKIEWICZ-BELDZINSKA, Maria; ROSE, Kristy; VLODAVETS, Dmitry; XIONG, Hui; ZANOTELI, Edmar; EL-KHAIRI, Muna; FUERST-RECKTENWALD, Sabine, et al
2020FIREFISH Part 2: Efficacy and safety of risdiplam (RG7916) in infants with Type 1 spinal muscular atrophy (SMA)SERVAIS, L.; BARANELLO, G.; MASSON, R.; MAZURKIEWICZ-BELDZINSKA, M.; ROSE, K.; VLODAVETS, D.; XIONG, H.; ZANOTELI, E.; EL-KHAIRI, M.; FUERST-RECKTENWALD, S., et al
2020FIREFISH Part 2: Efficacy and Safety of Risdiplam (RG7916) in Infants with Type 1 Spinal Muscular Atrophy (SMA)SERVAIS, Laurent; BARANELLO, Giovanni; MASSON, Riccardo; MAZURKIEWICZ-BELDZINSKA, Maria; ROSE, Kristy; VLODAVETS, Dmitry; XIONG, Hui; ZANOTELI, Edmar; EL-KHAIRI, Muna; FUERST-RECKTENWALD, Sabine, et al
2020FIREFISH Parts 1 and 2: 12-month pooled safety and efficacy outcomes of risdiplam (RG7916) in infants with Type 1 spinal muscular atrophy (SMA)SERVAIS, L.; BLOESPFLUG-TANGUY, O.; DARRAS, B.; DAY, J.; DECONINCK, N.; KLEIN, A.; MASSON, R.; MAZURKIEWICZ-BELDZINSKA, M.; MERCURI, E.; ROSE, K., et al
2021FIREFISH Parts 1 and 2: 24-Month Safety and Efficacy of Risdiplam in Type 1 SMAMASSON, R.; BOESPFLUG-TANGUY, O.; DARRAS, B. T.; DAY, J. W.; DECONINCK, N.; KLEIN, A.; MAZURKIEWICZ-BEDZISKA, M.; MERCURI, E.; ROSE, K.; SERVAIS, L., et al
2022FIREFISH Parts 1 and 2: 24-month Safety and Efficacy of Risdiplam in Type 1 SMADARRAS, Basil T.; BOESPFLUG-TANGUY, Odile; DAY, John W.; DECONINCK, Nicolas; KLEIN, Andrea; MASSON, Riccardo; MAZURKIEWICZ-BELDZINSKA, Maria; MERCURI, Eugenio; ROSE, Kristy; SERVAIS, Laurent, et al
2022FIREFISH Parts 1 and 2: 36-month safety and efficacy of risdiplam in Type 1 spinal muscular atrophyDECONINCK, N.; BARANELLO, G.; BOESPFLUG-TANGUY, O.; DAY, J.; KLEIN, A.; MASSON, R.; MAZURKIEWICZ-BELDZINSKA, M.; MERCURI, E.; ROSE, K.; SERVAIS, L., et al
2022FIREFISH Parts 1 and 2: 36-month safety and efficacy of risdiplam in Type 1 spinal muscular atrophy (SMA)SERVAIS, L.; BARANELLO, G.; BOESPFLUG-TANGUY, O.; DAY, J.; DECONINCK, N.; KLEIN, A.; MASSON, R.; MAZURKIEWICZ-BELDZINSKA, M.; MERCURI, E.; ROSE, K., et al
2023FIREFISH Parts 1 and 2: 36-month safety and efficacy of risdiplam in Type 1 spinal muscular atrophy (SMA)DARRAS, Basil; BARANELLO, Giovanni; BOESPFLUG-TANGUY, Odile; DAY, John; DECONINCK, Nicholas; KLEIN, Andrea; MASSON, Ricardo; MAZURKIEWICZ-BELDZINSKA, Maria; MERCURI, Eugenio; ROSE, Kristy, et al
2023FIREFISH Parts 1 and 2: 4-year efficacy and safety of risdiplam in Type 1 spinal muscular atrophy (SMA)MAZURKIEWICZ-BELDZINSKA, M.; BARANELLO, G.; BOESPFLUG-TANGUY, O.; DAY, J.; DECONINCK, N.; KLEIN, A.; MASSON, R.; MERCURI, E.; ROSE, K.; SERVAIS, L., et al
2017First results from the international LMNA-related congenital and childhood onset muscular dystrophy retrospective natural history studyYAOU, R. Ben; DABAJ, I.; YUN, P.; NORATO, G.; XIONG, H.; NASCIMENTO, A.; MAGGI, L.; SARKOZY, A.; MONGES, S.; BERTOLI, M., et al
2017Five-year follow-up of pediatric onset Neuromyelitis Optica Spectrum Disorders (NMOSD)PAOLILO, R. B.; PAZ, J. A.; APOSTOLOS-PEREIRA, S. L.; RIMKUS, C. D. M.; ARAUJO, A. L. P. C.; VENTURA, L. M. G. D. B.; PITOMBEIRA, M. S.; GOMES, A. B.; MATOS, A. D. M. B.; TORRETTA, P. H. B., et al
2022FOOT DROP AND COVID-19: A CASE SERIESCAMELO-FILHO, Antonio Edvan; ARANTES, Halisson; SODRE, Diego; ZANOTELI, Edmar; HEISE, Carlos
2015Force platform analysis after deep brain stimulation of peduncolopontine nucleus in progressive supranuclear palsy: Report of one caseSOUZA, C. O.; BRANT, R.; PARDINI, A. L.; BOARI, D.; TEIXEIRA, L. A.; TEIXEIRA, M. J.; BARBOSA, E. R.; FONOFF, E. T.
2012Functional convergence of parallel circuits within subthalamic nucleus: Intra-operative multichannel-microelectrode recording study during emotional, cognitive and motor tasksFONOFF, E. T.; EDGAR, M.; SAMESHIMA, K.; TEIXEIRA, M. J.; NICOLELIS, M. A. L.
2016Functional motor outcomes after globus pallidus internus deep brain stimulation in Huntington's disease - A case reportCAPATO, T. T. C.; CURY, R. G.; GIMAAES, R.; FONOFF, E. T.; HADDAD, M. S.
2016GABAa - Receptor and LGI1 Antibody Encephalitis in a Patient with ThymomaSIMABUKUROZ, Mateus; PETIT-PEDROL, Mar; LUCATO, Leandro; CASTRO, Luiz; NITRINI, Ricardo
2016Gordon Syndrome in the differencial diagnosis of kidneytubular acidosis-Case report and literature reviewSOUZA, A. M. C.; QUEIROZ, A. F.; VAISBICH, M. H.; CARDOSO, R. L.; KOK, F.
Showing results 115 to 134 of 316 < previous   next >